2m 2m 2m 2m 2m 2m 2m
JANUX THERAPEUTS (JANX)
NASDAQ
$12.41+$0.37 (+3.03%)
Price as of Nov 11, 2026 7:50 PM EST- $736.6MMarket Cap
- -58.30%1-Year Change
- BiotechnologyIndustry
JANUX THERAPEUTS (JANX)
$12.41+$0.37 (+3.03%)
JANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.04 | ||
Change | -$0.72 (-5.64%) | ||
Open | $12.75 | ||
High | $12.76 | ||
Low | $11.59 | ||
Previous Close | $12.76 | ||
Volume | 2,354,789 | ||
30-Day Average Volume | 972,541 | ||
1-Week Change | -32.44% | ||
1-Month Change | -34.53% | ||
1-Year Change | -58.30% | ||
3-Year Change | 99.34% | ||
5-Year Change | -49.58% | ||
Fundamentals | |||
Shares Outstanding | 61.2M | ||
Total Assets | $983.7M | ||
Market Cap | $736.6M | ||
Enterprise Value | $694.8M | ||
Period: QTR TTM FY | |||
Revenue | $9.3M | ||
Net Income | -$21.6M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$21.6M | ||
EBITDA | -$21.1M | ||
Net Working Capital | $905.1M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 75 | ||
P/B | 1 | ||
P/E | -35 | ||
PEG | -12 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue